# Inpatient Hospital Admissions for People with Obsessive-Compulsive Disorder (OCD). A Position Statement by the International College of Obsessive-Compulsive Spectrum Disorders. > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/inpatient-hospital-admissions-ocd-guidelines/ > **Published:** 2026-03-27T02:00:51-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T15:56:01-04:00 > **Clinical Summary:** Explore inpatient hospital admissions OCD guidelines for severe cases and treatment-refractory patients in this expert position statement. --- CED Clinical Relevance  #50Monitored Relevance  Early-stage or contextual signal requiring further evidence before action. 🔬 Evidence Watch  |  CED Clinic OcdAnxietyInpatientMental HealthTreatment Guidelines Journal Comprehensive psychiatry Study Type [Clinical Study](https://cedclinic.com/cannabis-hyperemesis-syndrome-psychiatric-risk/) Population Human participants Why This Matters This position statement addresses a critical gap in OCD treatment guidelines for the most severe cases requiring hospitalization. While cannabis is increasingly used by patients with OCD and [anxiety disorders](https://cedclinic.com/adolescent-cannabis-use-and-anxiety-research/), there are no established protocols for managing [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) during psychiatric inpatient admissions for OCD. Clinical Summary This expert consensus statement from the International College of Obsessive-Compulsive Spectrum Disorders outlines evidence-based recommendations for hospitalizing patients with severe OCD. The authors review indications for admission, including treatment-refractory cases and safety concerns, and describe inpatient treatment approaches showing significant reductions in OCD severity. The statement emphasizes that hospitalization remains uncommon for OCD compared to other psychiatric conditions but can be necessary when outpatient pharmacological and psychological interventions fail or pose safety risks. Dr. Caplan’s Take “I regularly encounter patients using cannabis for [OCD symptoms](https://cedclinic.com/cannabinoids-for-tic-disorders-ocd/), yet this comprehensive position statement makes no mention of cannabis considerations during inpatient care. This represents a notable clinical blind spot given the prevalence of [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) in this population.” Clinical Perspective 🧠 Clinicians treating OCD patients who use cannabis should develop protocols for managing cannabis use during potential psychiatric hospitalizations. Patients should be counseled that cannabis use history may affect inpatient treatment planning, particularly regarding medication interactions and withdrawal management during admission. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Inpatient%20hospital%20admissions%20for%20people%20with%20obsessive-compulsive%20disorder%20%28OCD...%20%40drcaplan&url=https%3A//pubmed.ncbi.nlm.nih.gov/41886794/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//pubmed.ncbi.nlm.nih.gov/41886794/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Inpatient%20hospital%20admissions%20for%20people%20with%20obsessive-compulsive%20disorder%20%28OCD...%20--%20via%20%40drcaplan.bsky.social%20https%3A//pubmed.ncbi.nlm.nih.gov/41886794/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41886794/](https://pubmed.ncbi.nlm.nih.gov/41886794/) Table of Contents - [FAQ](#FAQ)[Who issued this position statement on hospital care for OCD?](#Who_issued_this_position_statement_on_hospital_care_for_OCD) - [When might a person with OCD need to be hospitalized?](#When_might_a_person_with_OCD_need_to_be_hospitalized) - [Is hospitalization common for people with OCD?](#Is_hospitalization_common_for_people_with_OCD) - [Does inpatient treatment reduce OCD symptoms?](#Does_inpatient_treatment_reduce_OCD_symptoms) - [Related](#Related) ## FAQ ### Who issued this position statement on hospital care for OCD? It is an expert consensus statement from the International College of Obsessive-Compulsive Spectrum Disorders, published in the journal Comprehensive Psychiatry. It outlines evidence-based recommendations for hospitalizing patients with severe OCD, including when admission is indicated and what inpatient treatment approaches involve. ### When might a person with OCD need to be hospitalized? The position statement reviews indications for admission, including treatment-refractory cases, in which OCD has not responded to treatment, and safety concerns. Its recommendations are aimed at patients with severe OCD, the group for whom inpatient care is being considered. ### Is hospitalization common for people with OCD? No. The statement emphasizes that hospitalization remains uncommon for OCD compared with other psychiatric conditions. It can still be necessary when outpatient pharmacological and psychological interventions fail or pose safety risks. ### Does inpatient treatment reduce OCD symptoms? The statement describes inpatient treatment approaches that have shown significant reductions in OCD severity. It presents these approaches as part of its evidence-based recommendations for people with severe OCD who are admitted to hospital. {“@context”: “https://schema.org”, “@type”: “ScholarlyArticle”, “headline”: “Inpatient hospital admissions for people with obsessive-compulsive disorder (OCD). A position statement by the international college of obsessive-compulsive spectrum disorders.”, “url”: “https://pubmed.ncbi.nlm.nih.gov/41886794/”, “about”: “comprehensive psychiatry [clinical study](https://cedclinic.com/cannabis-hyperemesis-syndrome-psychiatric-risk/) inpatient hospital”, “isPartOf”: “Comprehensive psychiatry”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabis Use Disorder Treatment Europe Review](https://cedclinic.com/cannabis-use-disorder-treatment-europe-evidence-watch/) Review the latest evidence on [cannabis use disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/) treatments across Europe and their clinical relevance. [Read More](https://cedclinic.com/cannabis-use-disorder-treatment-europe-evidence-watch/) [New Clinical Insights on Cannabis and Patient Outcomes](https://cedclinic.com/new-clinical-insights-on-cannabis-and-patient-outcomes/) Explore emerging clinical data on cannabis effects and patient outcomes in mental health care. [Discover Insights](https://cedclinic.com/new-clinical-insights-on-cannabis-and-patient-outcomes/) 12 Best Alcohol Stocks to Buy Right Now – Insider Monkey An analysis of top alcohol stocks with potential investment opportunities in the current market. Learn More ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).